IRIS
RICCARDI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.997
EU - Europa 3.248
AS - Asia 2.030
OC - Oceania 22
AF - Africa 7
SA - Sud America 6
Totale 9.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.966
CN - Cina 1.898
UA - Ucraina 802
IE - Irlanda 744
FI - Finlandia 464
DE - Germania 379
SE - Svezia 348
IT - Italia 203
GB - Regno Unito 172
SG - Singapore 84
FR - Francia 76
CA - Canada 30
AU - Australia 20
BE - Belgio 15
IN - India 11
CZ - Repubblica Ceca 8
NL - Olanda 8
RU - Federazione Russa 7
IR - Iran 6
TR - Turchia 6
EG - Egitto 5
HK - Hong Kong 5
DK - Danimarca 4
KR - Corea 4
VN - Vietnam 4
GR - Grecia 3
RS - Serbia 3
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
JP - Giappone 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MX - Messico 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
YE - Yemen 1
Totale 9.310
Salva come PNG Salva come JPEG
Città #
Chandler 889
Jacksonville 861
Dublin 743
Nanjing 610
Boardman 284
Nanchang 243
Ashburn 216
Princeton 197
Lawrence 174
Shenyang 168
Changsha 163
Hebei 158
Wilmington 135
Helsinki 129
Medford 127
Jiaxing 111
Tianjin 107
Hangzhou 93
Beijing 88
Ann Arbor 74
Milan 71
Singapore 51
Verona 44
Woodbridge 37
Houston 36
Shanghai 33
Norwalk 30
Kunming 27
Toronto 24
Jinan 16
Seattle 16
Brussels 15
New York 14
San Francisco 14
Pavia 13
Auburn Hills 11
Des Moines 11
Fairfield 11
Los Angeles 11
San Genesio Ed Uniti 11
Melbourne 10
Brno 8
Falls Church 8
Ningbo 8
Zhengzhou 8
Haikou 7
Lanzhou 6
Chicago 5
Tappahannock 5
Al Fayyum 4
Canberra 4
Changchun 4
Guangzhou 4
Redwood City 4
Sydney 4
Taizhou 4
Andover 3
Bački Petrovac 3
Dallas 3
Hanoi 3
Lodi 3
Tuglie 3
Washington 3
Amsterdam 2
Athens 2
Auckland 2
Bari 2
Barnet 2
Bellshill 2
Borås 2
Buffalo 2
Coimbatore 2
Forest City 2
Incheon 2
Kazan 2
Naples 2
Nitra 2
Nocera Inferiore 2
Orange 2
Riyadh 2
Rockville 2
San Mateo 2
Sha Tin Wai 2
Taichung 2
Tokyo 2
Amman 1
Andria 1
Ardabil 1
Baranzate 1
Benevento 1
Bloomfield 1
Bridgeport 1
Brookline 1
Bussolengo 1
Cairo 1
Cesano 1
Cleveland 1
Colombo 1
Como 1
Dearborn 1
Totale 6.239
Salva come PNG Salva come JPEG
Nome #
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. 94
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients 91
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01). 83
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 80
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 76
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study 75
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 74
A study of biological behaviour of human brain tumors. Part I. Arachidonic acid metabolism and DNA content. 73
AIDS-associated non-Hodgkin's lymphomas in Italy: intravenous drug abusers versus homosexual men 72
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 72
G2 synchronization in human acute leukemia after VP 16 213 therapy. 71
A prospective comparison of a-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 71
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 70
Use of bisphosphonates in oncology: physiopathologic bases and clinical activity. 69
- GM-CSF increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications and bone marrow kinetics. 69
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 69
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 68
Cell kinetic characterization of human brain tumors 68
Anemie in oncologia. 68
Linee guida per la diagnosi, il trattamento e la riabilitazione del carcinoma polmonare 67
- Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational controlled trial. 67
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 67
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 66
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 66
Ploidy and proliferative activity in uterine tumors: an in vivo study using bromodeoxyuridine and flow cytometry. 65
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 65
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells. 65
I linfomi non Hodgkin (linfosarcomi, reticolosarcomi). 65
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. 64
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 64
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 64
Anemie megaloblastiche. 64
A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. 64
Angiogenesi: esperienze cliniche 63
The PAS reactivity of lymph-node blast cells in non-Hodgkin's malignant lymphomas. 63
Strategies of medical treatment for metastatic breast cancer 63
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy. 63
Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer. 63
Biologia e clinica del mieloma multiplo. 63
DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies 62
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 62
Expression of p53 protein during the cell cycle mesaured by flow cytometry in human leukemia. 62
Anemie megaloblastiche. 62
Changing clinical presentation of multiple myeloma. 62
Cytokinetic studies in two cases of plasma cell leukemia. 62
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. V. Effect of VP 16 213 studied with flow cytofluorometry and cytoautoradiography. 61
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. 60
Studio morfologico e citochimico dei megacariociti in 25 casi di displasie emopoietiche. 60
High-dose chemotherapy (HDT) with tandem autologous peripheral blood cells (PBPC) transplantation for patients with metastatic breast cancer (MBC) 60
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non lymphoblastic leukemia. 60
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 60
Effect of Vincristine on the bone marrow cells of patients with multiple myeloma: a cytomorphologic study. 59
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 59
Paclitaxel in anthracycline-treated breast cancer patients. 59
Double heterozygosity for haemoglobin Malmø [ß97 (FG4) His-Glu] and ß-thalassemia traits, with unusually high haematocrit values, in a Sicilian man. 59
Interferon alpha-2b in the long-term treatment of essential thrombocythemia. 59
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 59
Cell kinetic studies of human intracranial tumors. 59
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 59
Nuove strategie di impiego dei fattori di crescita mielopoietici. 58
Doubling the epirubicin dosage in the 5-fluorouracil, epirubicin and cyclophosphamide (FEC) regimen for advanced breast cancer: a prospective, randomized, multicentric study on antitumor effect and life quality 58
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients 58
Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term a-IFN treatment. 58
Interim analysis of the Grocta 8 adjuvant trial in breast cancer patients with ten or more involved nodes 57
New agents in medical oncology and the risk of venous thromboembolism. 57
Il carcinoma mammario operabile. Linee guida per la diagnosi, il trattamento e la riabilitazione. 57
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 57
A rapid cytofluorometric method for quantitative DNA determination on fixed smears. 56
Weekly taxanes in metastatic breast cancer. 56
HER-2 / neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma. 56
Expression of p170 multidrug resistance protein in multiple myeloma: a clinical study. 56
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. 56
Myelodysplastic syndromes: biologic and clinical aspects. 56
Applicazioni cliniche dei fattori di crescita emopoietici. 56
Gemcitabine and oxaliplatin to treat immunotherapy-resistant advanced renal cell carcinoma patients: final results of a single institution phase II study 56
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 56
VEGF-induced intracellular Ca2+oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells 56
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 55
Prerequisites for in vivo cell kinetic studies in patients. 55
Sequential intrahepatic and systemic fluoropyrimidines-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study. 55
Flow cytometric DNA index in the prognosis of colorectal cancer. 55
P-glycoprotein expression in multiple myeloma. 55
Intravenous carboplatin and etoposide for recurrent malignant glioma: a phase II study. 55
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 55
Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. 55
Intrathecal methotrexate neurotoxicity. 54
The use of peripheral blood haemopoietic progenitors mobilized with standard dose chemotherapy plus G-CSF to support multicyclic dose-intensive chemotherapy for advanced breast cancer. 54
Circulating progenitor cell release and funtional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients. 54
Applicazioni cliniche della citometria. 54
Fisiopatologia dell'eritrocito. 54
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 53
Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate. 53
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 53
Multiparametric assessment of the cell cycle effects of tamoxifen on MCF-7 human breast cancer cells. 52
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 52
Monoclonal antibody Ki-67 as marker of proliferative activity in monoclonal gammopathies. 52
Il trattamento medico del carcinoma mammario. 52
Cell proliferation and ploidy of human solid tumors: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry. 51
Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of the early evaluation of the course of the disease. 51
Proliferating cell nuclear antigen (PCNA) / cyclin expression during the cell cycle in normal and leukemic cells 51
Totale 6.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020717 0 0 0 144 0 169 9 152 3 164 63 13
2020/20211.346 151 116 49 145 2 204 7 169 56 199 193 55
2021/2022810 5 2 21 11 20 32 19 31 41 16 127 485
2022/20232.425 301 127 25 238 317 257 0 134 914 14 53 45
2023/2024718 130 146 25 62 68 167 11 28 8 29 27 17
2024/2025312 42 208 54 8 0 0 0 0 0 0 0 0
Totale 9.371